INS and type 1 diabetes mellitus: These transgenic mice, under the control of the rat insulin promoter (RIP), express antigens such as glycoproteins (GP) and nuclear proteins (NP) 142, resulting in the activation of the immune system through LCMV infection or the corresponding antigen immunity and eventually T1DM development.